The life sciences industry is currently facing several challenges that are significantly impacting drug and device manufacturing costs. In addition to these rising costs, regulatory developments such as the Inflation Reduction Act 2023 and upcoming patent cliffs are further exacerbating the situation. As a result, it has become imperative for life sciences enterprises to establish robust sales and marketing operations to remain competitive. Additionally, the increasing involvement of end-consumers/patients in their healthcare decisions, coupled with evolving Healthcare Practitioner (HCP) needs, has compelled life sciences enterprises to explore the use of digital tools and technologies to enhance their market positioning and ensure continued engagement with their stakeholders.
To effectively meet these evolving enterprise needs, providers are revamping their sales and marketing operations offerings. They are investing in a range of solutions, from point analytics such as HCP segmentation to large-scale multi-tower platform solutions covering marketing, promotion, and sales, along with investments in evolving technologies such as the metaverse for sales rep training.
In this report, we assess 17 providers featured on Everest Group’s Life Sciences Sales and Marketing Operations – Services PEAK Matrix®. Each profile provides a comprehensive overview of the provider’s service focus, key Intellectual Property (IP) / solutions and domain investments. The study will enable buyers to choose the best-fit provider based on their sourcing considerations, while providers will be able to benchmark their performance against each other.
This report features 17 life sciences sales and marketing operations service provider profiles and includes:
The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.